BioCentury
ARTICLE | Company News

Copernicus Gene, LXR deal

March 2, 1998 8:00 AM UTC

The companies will develop cancer gene therapy products integrating LXR's genes involved in control of apoptosis with Copernicus's DNA compaction and expression technologies for gene delivery. ...